Reducing dynamin 2 expression rescues X-linked centronuclear myopathy

Journal of Clinical Investigation

Volumn 124, Issue 3, 2014, Pages 1350-1363

  Cowling, Belinda S ^a   Chevremont, Thierry ^a   Prokic, Ivana ^a   Kretz, Christine ^a   Ferry, Arnaud ^b,c,d,e,f   Coirault, Catherine ^b,c,d,e   Koutsopoulos, Olga ^a   Laugel, Vincent ^g   Romero, Norma B ^b,c,d,e,h   Laporte, Jocelyn ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b INSERM   (France)

^c CNRS   (France)

^d SORBONNE UNIVERSITÉ   (France)

^e Institut de Myologie   (France)

^f UNIVERSITÉ PARIS DESCARTES   (France)

^g HÔPITAL DE HAUTEPIERRE   (France)

^h PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DYNAMIN II;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CENTRONUCLEAR MYOPATHY; CONTROLLED STUDY; DIAPHRAGM; DOWN REGULATION; EMBRYO DEVELOPMENT; FEMALE; HUMAN; LIFESPAN; LOSS OF FUNCTION MUTATION; MOUSE; MUSCLE STRENGTH; MUSCLE WEAKNESS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SARCOMERE; SKELETAL MUSCLE; X CHROMOSOME LINKED DISORDER; X LINKED CENTRONUCLEAR MYOPATHY;

ANIMALS; DIAPHRAGM; DOWN-REGULATION; DYNAMIN II; FEMALE; GENE EXPRESSION; HUMANS; MALE; MICE; MICE, KNOCKOUT; MUSCLE CONTRACTION; MUSCLE STRENGTH; MUSCLE, SKELETAL; MYOPATHIES, STRUCTURAL, CONGENITAL; PHENOTYPE; PROTEIN TYROSINE PHOSPHATASES, NON-RECEPTOR;

EID: 84896772002     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI71206     Document Type: Article

References (41)

1. Jungbluth H, Wallgren-Pettersson C, Laporte J. Centronuclear (myotubular) myopathy. Orphanet J Rare Dis. 2008;3:26.
2. Romero NB, Bitoun M. Centronuclear myopathies. Semin Pediatr Neurol. 2011;18(4):250-256.
3. Laporte J, et al. A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast. Nat Genet. 1996;13(2):175-182.
4. Nicot AS, et al. Mutations in amphiphysin 2 (BIN1) disrupt interaction with dynamin 2 and cause autosomal recessive centronuclear myopathy. Nat Genet. 2007;39(9):1134-1139.
5. Bitoun M, et al. Mutations in dynamin 2 cause dominant centronuclear myopathy. Nat Genet. 2005;37(11):1207-1209.
6. Laporte J, Kress W, Mandel JL. Diagnosis of X-linked myotubular myopathy by detection of myotubularin. Ann Neurol. 2001;50(1):42-46.
7. Laporte J, et al. MTM1 mutations in X-linked myotubular myopathy. Hum Mutat. 2000;15(5):393-409.
8. Tsai TC, et al. Characterization of MTM1 mutations in 31 Japanese families with myotubular myopathy, including a patient carrying 240 kb deletion in Xq28 without male hypogenitalism. Neuromuscul Disord. 2005;15(3):245-252.
9. Cowling BS, Toussaint A, Muller J, Laporte J. Defective membrane remodeling in neuromuscular diseases: insights from animal models. PLoS Genet. 2012;8(4):e1002595.
10. Buj-Bello A, et al. The lipid phosphatase myotubularin is essential for skeletal muscle maintenance but not for myogenesis in mice. Proc Natl Acad Sci U S A. 2002;99(23):15060-15065.
11. Pierson CR, et al. Modeling the human MTM1 p.R69C mutation in murine Mtm1 results in exon 4 skipping and a less severe myotubular myopathy phenotype. Hum Mol Genet. 2012;21(4):811-825.
12. Fetalvero KM, et al. Defective autophagy and mTORC1 signaling in myotubularin null mice. Mol Cell Biol. 2013;33(1):98-110.
13. Toussaint A, et al. Defects in amphiphysin 2 (BIN1) and triads in several forms of centronuclear myopathies. Acta Neuropathol. 2011;121(2):253-266.
14. Dowling JJ, et al. Loss of myotubularin function results in T-tubule disorganization in zebrafish and human myotubular myopathy. PLoS Genet. 2009;5(2):e1000372.
15. Al-Qusairi L, et al. T-tubule disorganization and defective excitation-contraction coupling in muscle fibers lacking myotubularin lipid phosphatase. Proc Natl Acad Sci U S A. 2009;106(44):18763-18768.
16. Amoasii L, et al. Myotubularin and PtdIns3P remodel the sarcoplasmic reticulum in muscle in vivo. J Cell Sci. 2013;126(pt 8):1806-1819.
17. Jones SM, Howell KE, Henley JR, Cao H, McNiven MA. Role of dynamin in the formation of transport vesicles from the trans-Golgi network. Science. 1998;279(5350):573-577.
18. van der Bliek AM, Meyerowitz EM. Dynamin-like protein encoded by the Drosophila shibire gene associated with vesicular traffic. Nature. 1991; 351(6325):411-414.
19. Praefcke GJ, McMahon HT. The dynamin superfamily: universal membrane tubulation and fission molecules? Nat Rev Mol Cell Biol. 2004;5(2):133-147.
20. Ferguson SM, De Camilli P. Dynamin, a membrane-remodelling GTPase. Nat Rev Mol Cell Biol. 2012;13(2):75-88.
21. McNiven MA, Kim L, Krueger EW, Orth JD, Cao H, Wong TW. Regulated interactions between dynamin and the actin-binding protein cortactin modulate cell shape. J Cell Biol. 2000;151(1):187-198.
22. Takei K, McPherson PS, Schmid SL, De Camilli P. Tubular membrane invaginations coated by dynamin rings are induced by GTP-gamma S in nerve terminals. Nature. 1995;374(6518):186-190.
23. Roux A, Uyhazi K, Frost A, De Camilli P. GTPdependent twisting of dynamin implicates constriction and tension in membrane fission. Nature. 2006;441(7092):528-531.
24. Faelber K, et al. Crystal structure of nucleotide-free dynamin. Nature. 2011;477(7366):556-560.
25. Zuchner S, et al. Mutations in the pleckstrin homology domain of dynamin 2 cause dominant intermediate Charcot-Marie-Tooth disease. Nat Genet. 2005;37(3):289-294.
26. Wang L, Barylko B, Byers C, Ross JA, Jameson DM, Albanesi JP. Dynamin 2 mutants linked to centronuclear myopathies form abnormally stable polymers. J Biol Chem. 2010;285(30):22753-22757.
27. Kenniston JA, Lemmon MA. Dynamin GTPase regulation is altered by PH domain mutations found in centronuclear myopathy patients. EMBO J. 2010;29(18):3054-3067.
28. Cowling BS, et al. Increased expression of wild-type or a centronuclear myopathy mutant of dynamin 2 in skeletal muscle of adult mice leads to structural defects and muscle weakness. Am J Pathol. 2011;178(5):2224-2235.
29. Durieux AC, et al. A centronuclear myopathydynamin 2 mutation impairs skeletal muscle structure and function in mice. Hum Mol Genet. 2010;19(24):4820-4836.
30. Liu N, et al. Mice lacking microRNA 133a develop dynamin 2-dependent centronuclear myopathy. J Clin Invest. 2011;121(8):3258-3268.
31. Ferguson SM, et al. Coordinated actions of actin and BAR proteins upstream of dynamin at endocytic clathrin-coated pits. Dev Cell. 2009;17(6):811-822.
32. Ayadi A, et al. Mouse large-scale phenotyping initiatives: overview of the European Mouse Disease Clinic (EUMODIC) and of the Wellcome Trust Sanger Institute Mouse Genetics Project. Mamm Genome. 2012;23(9-10):600-610.
33. Hnia K, et al. Myotubularin controls desmin intermediate filament architecture and mitochondrial dynamics in human and mouse skeletal muscle. J Clin Invest. 2011;121(1):70-85.
34. Amoasii L, et al. Phosphatase-dead myotubularin ameliorates x-linked centronuclear myopathy phenotypes in mice. PLoS Genet. 2012;8(10):e1002965.
35. Beggs AH, et al. MTM1 mutation associated with X-linked myotubular myopathy in Labrador retrievers. Proc Natl Acad Sci U S A. 2010; 107(33):14697-14702.
36. Al-Qusairi L, Laporte J. T-tubule biogenesis and triad formation in skeletal muscle and implication in human diseases. Skelet Muscle. 2011;1(1):26.
37. Schuler M, Ali F, Metzger E, Chambon P, Metzger D. Temporally controlled targeted somatic mutagenesis in skeletal muscles of the mouse. Genesis. 2005;41(4):165-170.
38. Miniou P, Tiziano D, Frugier T, Roblot N, Le Meur M, Melki J. Gene targeting restricted to mouse striated muscle lineage. Nucleic Acids Res. 1999;27(19):e27.
39. Shnyrova AV, et al. Geometric catalysis of membrane fission driven by flexible dynamin rings. Science. 2013;339(6126):1433-1436.
40. Bohm J, et al. Mutation spectrum in the large GTPase dynamin 2, and genotype-phenotype correlation in autosomal dominant centronuclear myopathy. Hum Mutat. 2012;33(6):949-959.
41. Tinsley JM, Potter AC, Phelps SR, Fisher R, Trickett JI, Davies KE. Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene. Nature. 1996;384(6607):349-353.